| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and CEO
2 companies
John J Nicols is Director at CDXS, with reported holdings spanning 2 companies. John J Nicols's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $906K at current prices.
Our model assigns John J Nicols a strong insider score of 86/100, based on 28 past trades. Over a 12-month horizon, all 28 of those trades were profitable, with an average 12-month return of +60.0%.
John J Nicols's largest disclosed position is in CDXS as Director, worth about $847K. The CDXS filings lean toward selling, a net 1,245,858 shares.
John J Nicols has 46 Form 4 filings on record from February 2015 to February 2026, across 2 companies: Director at Scientific Industries (SCND), 2023–2026; Director at Codexis (CDXS), 2015–2023.
The 119 reported transactions were 47 open-market sales, 34 option exercises, 18 option or other derivative awards and 9 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $311K and 20 sales worth about $16.2M.
The largest open-market purchase was 10,000 shares of CDXS at an average $13.30 on August 20, 2019, about $133K.
The largest open-market sale was 73,500 shares of CDXS at an average $39.32 on November 11, 2021, about $2.9M. Twelve months later CDXS was down 82%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2025 | SCND Scientific Industries Inc | Director | Buy | 15,000 | $1.00 | $15,000.00 | +100.0% | - | - | |
| Dec 13, 2023 | SCND Scientific Industries Inc | Director | Buy | 15,000 | $2.00 | $30,000.00 | New | - | - | |
| Apr 18, 2023 | CDXS Codexis, Inc. | Director | Sale+OE10b5-1 | 71,428 | $4.19 | $299,251.18 | -8.4% | -22.8% | -33.7% | |
| Mar 16, 2023 | CDXS Codexis, Inc. | Director | Sale+OE | 71,428 | $4.10 | $292,811.94 | -8.4% | -33.0% | -19.2% | |
| Feb 24, 2023 | CDXS Codexis, Inc. | Director | Sale+OE | 75,499 | $5.11 | $385,871.94 | -8.8% | -47.6% | -35.9% | |
| Jan 24, 2023 | CDXS Codexis, Inc. | Director | Sale+OE | 75,499 | $6.50 | $490,936.67 | -8.4% | -34.3% | -57.6% | |
| Dec 12, 2022 | CDXS Codexis, Inc. | Director | Sale+OE | 75,499 | $5.67 | $427,815.92 | -8.0% | -25.0% | -64.5% | |
| Nov 16, 2022 | CDXS Codexis, Inc. | Director | Sale+OE | 75,500 | $6.59 | $497,550.92 | -7.7% | -6.2% | -66.4% | |
| Oct 28, 2022 | CDXS Codexis, Inc. | Director | Sale+OE | 75,502 | $5.61 | $423,569.59 | -7.4% | +14.1% | -72.7% | |
| Oct 6, 2022 | CDXS Codexis, Inc. | Director | Sale+OE | 75,503 | $6.02 | $454,234.00 | -7.1% | -15.5% | -65.3% |